{
  "trial_id": "NCT03916744",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG Performance Status, tumor size, ER status, HER2 status, menopausal status, baseline heart rate, baseline QTc interval, organ function (liver, kidney), prior medical history, prior surgical history, baseline Ki67 levels.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status at Baseline",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Initial Staging of Breast Cancer (Breast Cancer History)",
        "Tumor Grade (Breast Cancer History)",
        "Nodal Status (Breast Cancer History)"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "tumor size",
        "ER status",
        "HER2 status",
        "menopausal status",
        "baseline heart rate",
        "baseline QTc interval",
        "organ function (liver, kidney)",
        "prior medical history",
        "prior surgical history",
        "baseline Ki67 levels."
      ]
    },
    "processed-gen-response": "Age, sex, race, ethnicity, ECOG Performance Status, tumor size, ER status, HER2 status, menopausal status, baseline heart rate, baseline QTc interval, organ function (liver, kidney), prior medical history, prior surgical history, baseline Ki67 levels."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, Tumor Size, Stage of Breast Cancer, ER Status, HER2 Status, ECOG Performance Status, Organ Function,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status at Baseline",
          "ECOG Performance Status"
        ],
        [
          "Initial Staging of Breast Cancer (Breast Cancer History)",
          "Stage of Breast Cancer"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Tumor Grade (Breast Cancer History)",
        "Nodal Status (Breast Cancer History)"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Tumor Size",
        "ER Status",
        "HER2 Status",
        "Organ Function"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, Tumor Size, Stage of Breast Cancer, ER Status, HER2 Status, ECOG Performance Status, Organ Function"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Postmenopausal Status, Region of Enrollment, Body Mass Index, ECOG Performance Status, Tumor Size, ER Status, HER2 Status, Ki67 Status, Prior Breast Cancer History, Prior Hormone Replacement Therapy Use.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status at Baseline",
          "ECOG Performance Status"
        ],
        [
          "Initial Staging of Breast Cancer (Breast Cancer History)",
          "Prior Breast Cancer History"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race/Ethnicity",
        "Tumor Grade (Breast Cancer History)",
        "Nodal Status (Breast Cancer History)"
      ],
      "remaining_candidate_features": [
        "Postmenopausal Status",
        "Region of Enrollment",
        "Body Mass Index",
        "Tumor Size",
        "ER Status",
        "HER2 Status",
        "Ki67 Status",
        "Prior Hormone Replacement Therapy Use."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Postmenopausal Status, Region of Enrollment, Body Mass Index, ECOG Performance Status, Tumor Size, ER Status, HER2 Status, Ki67 Status, Prior Breast Cancer History, Prior Hormone Replacement Therapy Use."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, race, ethnicity, body mass index (BMI), ECOG Performance Status, menopausal status, duration of menopause, history of hormone replacement therapy, breast cancer stage, tumor size, ER and HER2 status, Ki67 index at baseline, prior breast cancer history, family history of breast cancer, smoking status, alcohol consumption.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance Status at Baseline",
          "ECOG Performance Status"
        ],
        [
          "Initial Staging of Breast Cancer (Breast Cancer History)",
          "breast cancer stage"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race/Ethnicity",
        "Tumor Grade (Breast Cancer History)",
        "Nodal Status (Breast Cancer History)"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "body mass index (BMI)",
        "menopausal status",
        "duration of menopause",
        "history of hormone replacement therapy",
        "tumor size",
        "ER and HER2 status",
        "Ki67 index at baseline",
        "prior breast cancer history",
        "family history of breast cancer",
        "smoking status",
        "alcohol consumption."
      ]
    },
    "processed-gen-response": "Age, race, ethnicity, body mass index (BMI), ECOG Performance Status, menopausal status, duration of menopause, history of hormone replacement therapy, breast cancer stage, tumor size, ER and HER2 status, Ki67 index at baseline, prior breast cancer history, family history of breast cancer, smoking status, alcohol consumption."
  }
}